Table 1 Results study characteristics
Variable | Result |
|---|---|
Year of publication, median (range) | 2016 (2008–2020) |
Number of authors, median (range) | 5 (2–10) |
Geographical origin, n (%) | |
Europe | 10 (48%) |
Asia | 3 (14%) |
North America | 4 (19%) |
South America | 1 (5%) |
Australia | 3 (14%) |
Africa | 0 |
Nuclear medicine affiliation, n (%) | |
Yes | 20(95%) |
No | 1(5%) |
Study design, n (%) | |
Cohort studies | 7 (33%) |
Number of patients, median (range) | 412 (33–1150) |
Case reports | 14 (67%) |
68 Ga-Tracer of choice, n (%) | |
DOTATATE | 15 (71%) |
DOTATOC | 4 (19%) |
DOTANOC | 2 (10%) |
Impact factor, n (%) | |
Journals without impact factor | 3 (14%) |
Journals with impact factor | 18 (86%) |
Impact factor, median (range) | 4,241 (1.085–6.622) |